FDA Permits Marketing of First U.S. Test for TB Bacteria and Rifampicin Resistance

News   Jul 26, 2013

 
FDA Permits Marketing of First U.S. Test for TB Bacteria and Rifampicin Resistance
 
 
 

RELATED ARTICLES

Interaction Mechanism for 'Boiled Noodle' Proteins Identified

News

Even unstructured proteins can bind together with incredible strength using electrostatic attraction, a new study suggests.

READ MORE

Biomarkers Could Produce Preeclampsia Diagnostic Test

News

Small non-coding RNA analysis may revolutionize how doctors assess preeclampsia risk.

READ MORE

Shire, Microsoft and EURORDIS Form Global Commission to Accelerate Rare Disease Diagnosis

News

The alliance aims to shorten the often multi-year journey that patients and families endure before being diagnosed with a rare disease.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE